Clinical trial
A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed…
NCT00144066 · West Japan Thoracic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00144066 |
|---|---|
| Title | A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer |
| Official title | A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer |
| Lead sponsor | West Japan Thoracic Oncology Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | platinum-based chemotherapy alone (up to six cycles), platinum-based chemotherapy followed by maintenance therapy with gefitinib |
| Enrollment | 600 |
| Start date | Jan 1, 2003 |
| First posted | Sep 2, 2005 |
| Last update posted | Sep 2, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: